Abstract 93P
Background
Immune system plays an important role in the development, treatment response, and progression of triple-negative breast cancer. Here, we aimed to assess the dynamics of cell populations and their transcriptome changes during neoadjuvant chemotherapy (NACT) in triple-negative breast cancer patients.
Methods
Mononuclear cells were purified from peripheral venous blood before NACT, after 3rd and 21st days of NACT using a ficoll density gradient. Total cell concentration and viability (Calcein/DRAQ7) were assessed by flow cytometry (Cytoflex, Beckman Coulter). Single cells were sequenced on a NextSeq 2000 (Illumina) using targeted panel Immune Response from Rhapsody Express (Becton Dickinson). Data were analyzed using Seurat and SingleR.
Results
According to single cell sequencing data we revealed 10 main populations of mononuclear leukocytes: В cells (CD79+), NK cells (KIR2DL+), classical (CD14+) and non-classical (CD16+) monocytes, Т-cytotoxic cells (CD8+), Т-helpers (CD4+), T-regs (FOXP3+), CD4 memory cells (CD4+, IL32+, KLRB+, RGS1+), CD8 naïve (CD8+, LEF1+, CCR7+, PIK3IP1+), CD4 naïve (CD4+, LEF1+, CCR7+, PIK3IP1+). 3 days after NACT overexpression of BAX, FOSb, JUN, CXCR4, CD69 genes were observed, that mediating apoptosis of CD4 memory/naïve and CD8 naïve lymphocytes, T regs and monocytes; chemotaxis and proliferation of NK and Т-cytotoxic lymphocytes. The population of blood monocytes was selectively depleted (up to 3%). 21 days after NACT overexpression of CCR2, S100A9, ITGAM, CXCL8, CCL4, CCL5 genes were observed, mediating migration of monocytes to tissue, chemotaxis of immune cells and inflammation. The population of monocytes increased by up to 20%.
Conclusions
Chemotherapy affects the quantitative and qualitative composition of mononuclear leukocytes and changes their transcriptomic profile towards proinflammatory activation. This study was funded by the Russian Science Foundation (grant #22-75-10128).
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Russian Science Foundation, no.22-75-10128.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
24P - Single cell transcriptomics of the immune cells during chemotherapy in triple-negative breast cancer patients
Presenter: Anastasia Frolova
Session: Poster session 09
25P - Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
Presenter: Tadaaki Yamada
Session: Poster session 09
26P - Pre-clinical modelling and treatment of BRAF mutated colorectal cancer
Presenter: Mark White
Session: Poster session 09
27P - Extending a classification system for atypical BRAF mutations to improve targeted therapies in colorectal cancer cells
Presenter: Abhinav Madduri
Session: Poster session 09
28P - Xanthine oxidase as a prognostic factor in colorectal cancer metastatic disease
Presenter: Anton Burlaka
Session: Poster session 09
29P - The effect of cancer associated fibroblast-derived activin A on colorectal cancer progression
Presenter: Simone Stang
Session: Poster session 09
30P - Prostaglandin signaling in tumour stroma interaction in colorectal cancer and its impact on the secretome and functional relevance
Presenter: Mario Macia-Guardado
Session: Poster session 09
31P - Cell-free tumor microRNA as early biomarkers of high-grade cervical intraepithelial neoplasia using liquid biopsy
Presenter: Stéphanie Calfa
Session: Poster session 09
32P - Epigenetic reprogramming induced prostaglandin E2 accumulation via overactivated arachidonic acid metabolism during trastuzumab resistance formation of HER2-positive breast cancer
Presenter: yongmei yin
Session: Poster session 09
33P - Visualizing trastuzumab-deruxtecan action in HER2+ breast cancer cells at nanoscale
Presenter: Katia Cortese
Session: Poster session 09